Next Article in Journal
The Potential of Long-Acting, Tissue-Targeted Synthetic Nanotherapy for Delivery of Antiviral Therapy Against HIV Infection
Next Article in Special Issue
West Nile Virus Epidemic in Germany Triggered by Epizootic Emergence, 2019
Previous Article in Journal
In-Gel Isolation and Characterization of Large (and Other) Phages
Previous Article in Special Issue
Novel Toscana Virus Reverse Genetics System Establishes NSs as an Antagonist of Type I Interferon Responses

Development of a Reverse Genetics System for Toscana Virus (Lineage A)

MRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, Scotland, UK
IVPC UMR754, INRAE, Univ Lyon, Université Claude Bernard Lyon1, EPHE, PSL Research University, F-69007 Lyon, France
Authors to whom correspondence should be addressed.
Viruses 2020, 12(4), 411;
Received: 4 March 2020 / Revised: 30 March 2020 / Accepted: 3 April 2020 / Published: 7 April 2020
(This article belongs to the Special Issue Emerging Arboviruses)
Toscana virus (TOSV) is a Phlebovirus in the Phenuiviridae family, order Bunyavirales, found in the countries surrounding the Mediterranean. TOSV is an important cause of seasonal acute meningitis and encephalitis within its range. Here, we determined the full sequence of the TOSV strain 1500590, a lineage A virus obtained from an infected patient (Marseille, 2007) and used this in combination with other sequence information to construct functional cDNA plasmids encoding the viral L, M, and S antigenomic sequences under the control of the T7 RNA promoter to recover recombinant viruses. Importantly, resequencing identified two single nucleotide changes to a TOSV reference genome, which, when corrected, restored functionality to the polymerase L and made it possible to recover infectious recombinant TOSV (rTOSV) from cDNA, as well as establish a minigenome system. Using reverse genetics, we produced an NSs-deletant rTOSV and also obtained viruses expressing reporter genes instead of NSs. The availability of such a system assists investigating questions that require genetic manipulation of the viral genome, such as investigations into replication and tropism, and beyond these fundamental aspects, also the development of novel vaccine design strategies. View Full-Text
Keywords: reverse genetics; Phlebovirus; Bunyavirales; Toscana virus reverse genetics; Phlebovirus; Bunyavirales; Toscana virus
Show Figures

Figure 1

MDPI and ACS Style

Alexander, A.J.T.; Confort, M.-P.; Desloire, S.; Dunlop, J.I.; Kuchi, S.; Sreenu, V.B.; Mair, D.; Wilkie, G.S.; Da Silva Filipe, A.; Brennan, B.; Ratinier, M.; Arnaud, F.; Kohl, A. Development of a Reverse Genetics System for Toscana Virus (Lineage A). Viruses 2020, 12, 411.

AMA Style

Alexander AJT, Confort M-P, Desloire S, Dunlop JI, Kuchi S, Sreenu VB, Mair D, Wilkie GS, Da Silva Filipe A, Brennan B, Ratinier M, Arnaud F, Kohl A. Development of a Reverse Genetics System for Toscana Virus (Lineage A). Viruses. 2020; 12(4):411.

Chicago/Turabian Style

Alexander, Akira J.T., Marie-Pierre Confort, Sophie Desloire, James I. Dunlop, Srikeerthana Kuchi, Vattipally B. Sreenu, Daniel Mair, Gavin S. Wilkie, Ana Da Silva Filipe, Benjamin Brennan, Maxime Ratinier, Frédérick Arnaud, and Alain Kohl. 2020. "Development of a Reverse Genetics System for Toscana Virus (Lineage A)" Viruses 12, no. 4: 411.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop